Page last updated: 2024-08-26

selenium and temozolomide

selenium has been researched along with temozolomide in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Amin, S; Cheng, Y; Huber-Keener, KJ; Liao, J; Ren, X; Sharma, AK; Sk, UH; Sun, YW; Yang, JM; Zhang, L; Zhang, Y1
Övey, İS; Özkal, B1
Berthier, S; Boutonnat, J; Chovelon, B; Faure, P; Garrel, C; Hazane-Puch, F; Larrouquère, L; Paucot, H; Vacchina, V1

Other Studies

3 other study(ies) available for selenium and temozolomide

ArticleYear
Rational incorporation of selenium into temozolomide elicits superior antitumor activity associated with both apoptotic and autophagic cell death.
    PloS one, 2012, Volume: 7, Issue:4

    Topics: Animals; Antineoplastic Agents, Alkylating; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Brain Neoplasms; Calpain; Cell Line, Tumor; Dacarbazine; Glioma; Humans; Male; Melanoma; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Nude; Selenium; Skin Neoplasms; Temozolomide; Xenograft Model Antitumor Assays

2012
Selenium enhances TRPA1 channel-mediated activity of temozolomide in SH-SY5Y neuroblastoma cells.
    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2020, Volume: 36, Issue:6

    Topics: Apoptosis; Cell Line, Tumor; Humans; Neuroblastoma; Reactive Oxygen Species; Selenium; Temozolomide; TRPA1 Cation Channel

2020
Preclinical Evaluation of Sodium Selenite in Mice: Toxicological and Tumor Regression Studies after Striatum Implantation of Human Glioblastoma Stem Cells.
    International journal of molecular sciences, 2021, Sep-30, Volume: 22, Issue:19

    Topics: Animals; Apoptosis; Brain Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Corpus Striatum; Glioblastoma; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplastic Stem Cells; Selenium; Sodium Selenite; Temozolomide; Trace Elements; Treatment Outcome; Tumor Burden; Xenograft Model Antitumor Assays

2021